|
|
||||||||
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
Submitted 22 April 2005 ; accepted in final form 7 June 2005
Differences in gender are in part responsible for the development of insulin resistance (IR) and associated hypertension. Currently, it is unclear whether these differences are dictated by gender itself or by the relative changes in plasma estrogen and/or testosterone. We investigated the interrelationships between testosterone and estrogen in the progression of IR and hypertension in vivo in intact and gonadectomized fructose-fed male rats. Treatment with estrogen significantly reduced the testosterone levels in both normal chow-fed and fructose-fed rats. Interestingly, fructose feeding induced a relative increase in estradiol levels, which did not affect IR in both intact and gonadectomized fructose-fed rats. However, increasing the estrogen levels improved insulin sensitivity in both intact and gonadectomized fructose-fed rats. In intact males, fructose feeding increased the blood pressure (140 ± 2 mmHg), which was prevented by estrogen treatment. However, the blood pressure in the fructose-fed estrogen rats (125 ± 1 mmHg) was significantly higher than that of normal chow-fed (113 ± 1 mmHg) and fructose-fed gonadectomized rats. Estrogen treatment did not affect the blood pressure in gonadectomized fructose-fed rats (105 ± 2 mmHg). These data suggest the existence of a threshold value for estrogen below which insulin sensitivity is unaffected. The development of hypertension in this model is dictated solely by the presence or absence of testosterone. In summary, the development of IR and hypertension is governed not by gender per se but by the interactions of specific sex hormones such as estrogen and testosterone.
hyperinsulinemia; fructose hypertensive rat; gender; estrogen; testosterone
This article has been cited by other articles:
![]() |
R. Miller, D. D'Agostino, C. Erlanson-Albertsson, and M. E. Lowe Enterostatin deficiency increases serum cholesterol but does not influence growth and food intake in mice Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E856 - E865. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Romero-Aleshire, M. K. Diamond-Stanic, A. H. Hasty, P. B. Hoyer, and H. L. Brooks Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R587 - R592. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, L. Qi, N. Qiao, H. K. Choi, G. Curhan, K. L. Tucker, and A. Ascherio Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women Hypertension, August 1, 2007; 50(2): 306 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vasudevan, P. R. Nagareddy, and J. H. McNeill Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3058 - H3064. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |